Yatharth Hospital & Trauma Care Services credit ratios

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023

253	253	0.0	83.1	264
−10.0	−10.0	−515	−156	225
0.14×	0.14×	0.00×	0.09×	1.44×
−0.01×	−0.01×	−0.31×	−0.18×	1.23×
0.87×	0.87×	0.00×	0.46×	2.50×
−0.03×	−0.03×	−2.34×	−0.86×	2.14×
31.26×	31.26×	21.71×	15.99×	10.61×
12.3%	12.3%	0.0%	8.7%	59.0%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

YATHARTH₹923.30

Yatharth Hospital & Trauma Care Services Ltd.

· Pharma & Health

₹ CrorePeersMAXHEALTH MEDANTA FORTIS VIYASH THYROCARE SUPRIYA STAR SPARCMcap ₹8,896 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Total Debt	263.8	83.1	0.0	253.3	253.3
Net Debt	225.3	-155.6	-514.8	-10.0	-10.0
Total Debt/Equity	1.44	0.09	0.00	0.14	0.14
Net Debt/Equity	1.23	-0.18	-0.31	-0.01	-0.01
Total Debt/EBITDA	2.50	0.46	0.00	0.87	0.87
Net Debt/EBITDA	2.14	-0.86	-2.34	-0.03	-0.03
Interest Coverage (EBIT/Interest)	10.61	15.99	21.71	31.26	31.26
Total Debt/Total Capital %	59.04	8.68	0.00	12.29	12.29

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.